ACC 2020: Updates from the PARTNER 3 Trial — Dr Michael J Mack
- Видео
- О видео
- Скачать
- Поделиться
ACC 2020: Updates from the PARTNER 3 Trial — Dr Michael J Mack
Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic outcomes from the PARTNER 3 low-risk randomized trial. The goal of PARTNER 3 was to evaluate transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR) among low-risk patients with symptomatic severe aortic stenosis. Filmed remotely from Texas.
913 | 5 год. назад | 8 - 0
Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic outcomes from the PARTNER 3 low-risk randomized trial.
The goal of PARTNER 3 was to evaluate transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR) among low-risk patients with symptomatic severe aortic stenosis.
Filmed remotely from Texas.
Чтобы скачать видео "ACC 2020: Updates from the PARTNER 3 Trial — Dr Michael J Mack" передвинте ползунок вправо
- Комментарии
Комментарии ФБ